TY - JOUR
T1 - Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination
AU - Thomson, Scott A.
AU - Sherritt, Martina A.
AU - Medveczky, Jill
AU - Elliott, Suzanne L.
AU - Moss, Denis J.
AU - Fernando, Germain J.P.
AU - Brown, Lorena E.
AU - Suhrbier, Andreas
PY - 1998/2/15
Y1 - 1998/2/15
N2 - Development of CD8 αβ CTL epitope-based vaccines requires an effective strategy capable of co-delivering large numbers of CTL epitopes. Here we describe a DNA plasmid encoding a polyepitope or 'polytope' protein, which contained multiple contiguous minimal murine CTL epitopes. Mice vaccinated with this plasmid made MHC-restricted CTL responses to each of the epitopes, and protective CTL were demonstrated in recombinant vaccinia virus, influenza virus, and tumor challenge models. CTL responses generated by polytope DNA plasmid vaccination lasted for 1 yr, could be enhanced by co-delivering a gene for granulocyte-macrophage CSF, and appeared to be induced to be induced in the absence of CD4 T cell-mediated help. The ability to deliver large numbers of CTL epitopes using relatively small polytope constructs and DNA vaccination technology should find application in the design of human epitope-based CTL vaccines, in particular in vaccines against EBV, HIV, and certain cancers.
AB - Development of CD8 αβ CTL epitope-based vaccines requires an effective strategy capable of co-delivering large numbers of CTL epitopes. Here we describe a DNA plasmid encoding a polyepitope or 'polytope' protein, which contained multiple contiguous minimal murine CTL epitopes. Mice vaccinated with this plasmid made MHC-restricted CTL responses to each of the epitopes, and protective CTL were demonstrated in recombinant vaccinia virus, influenza virus, and tumor challenge models. CTL responses generated by polytope DNA plasmid vaccination lasted for 1 yr, could be enhanced by co-delivering a gene for granulocyte-macrophage CSF, and appeared to be induced to be induced in the absence of CD4 T cell-mediated help. The ability to deliver large numbers of CTL epitopes using relatively small polytope constructs and DNA vaccination technology should find application in the design of human epitope-based CTL vaccines, in particular in vaccines against EBV, HIV, and certain cancers.
UR - http://www.scopus.com/inward/record.url?scp=0032519428&partnerID=8YFLogxK
M3 - Article
SN - 0022-1767
VL - 160
SP - 1717
EP - 1723
JO - Journal of Immunology
JF - Journal of Immunology
IS - 4
ER -